By Julie Steenhuysen
CHICAGO (Reuters) - The first two COVID-19 vaccines to enter large-scale U.S.
trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters.
Moderna and Pfizer, which has partnered with Germany's BioNTech, this week separately launched clinical trials that use a new and unproven gene-based technology. Both companies are requiring proof of a negative pregnancy test and a commitment to using birth.....